News | March 11, 2023
Marksans Pharma announces USFDA approval for Famotidine Tablets
Marksans' OTC Famotidine Tablets USP are acid reducers
Marksans' OTC Famotidine Tablets USP are acid reducers
The inspection concluded with no observations
Time to combine innovation, access and technology to deliver positive patient outcomes
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Digital success is contingent on the way a company organizes itself around technology
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme
Subscribe To Our Newsletter & Stay Updated
